AnjanJayantilalPatelMD

PubMed

• 113 citations
  Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-...
  Byoung Chul Cho, Delvys Rodriguez Abreu, Maen Hussein, Manuel Cobo, Anjan J Patel, Nevena Secen, Ki Hyeong Lee, Bartomeu Massuti, Sandrine Hiret, James Chih Hsin Yang,...> ;The Lancet. Oncology. 2022 Jun 1
• 9 citations
  Pharmacist-led patient education and adverse event management in patients with non-small cell lung cancer receiving afatinib in a community-based, real-world clinical ...
  Natasha Khrystolubova, Monica Shieh, Anjan J Patel, Ray Bailey> ;Journal of Oncology Pharmacy Practice. 2020 Jan 1
• 2 citations
  Positive Response and Increase in ADAMTS13 with Scheduled Rituximab in a Patient with Relapsing Thrombotic Thrombocytopenic Purpura.
  Bahaa Amer, Anjan Patel> ;Cureus. 2019 Jul 1
• 1 citations
  A Peculiar Adenocarcinoma.
  Ameet Patel, Anjan Patel> ;JAMA Oncology. 2017 Dec 7
• Reply: clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacem...
  Jessica Michelle Cope, Jennifer Bushwitz, Guohua An, Abigail Antigua, Anjan Patel, Marc Zumberg> ;The Annals of Pharmacotherapy. 2015 May 1
• Clinical Experience With Prophylactic Fondaparinux in Critically Ill Patients With Moderate to Severe Renal Impairment or Renal Failure Requiring Renal Replacement The...
  Cope, J.,Bushwitz, J.,An, G.,Antigua, A.,Patel, A.,Zumberg, M.> ;Ann Pharmacother. 2014 Dec 18
• 7 citations
  Successful percutaneous coronary intervention in a patient with combined deficiency of FV and FVIII due to novel compound heterozygous mutations in LMAN1
  Anjan J Patel, Hui-hui Liu, Robert A Lager, Vera Malkovska, Bin Zhang> ;Haemophilia. 2013 Jul 1
• Join now to see all